GenScript rents in Van Iterson House, Lesaffre in Beijerinck Center on Biotech Campus Delft

a.s.r. real estate has entered into a lease agreement with GenScript Biotech Corporation and Lesaffre on behalf of the ASR Dutch Science Park Fund. Planet B.io and the science park fund are pleased to announce that these companies are joining the growing ecosystem at Biotech Campus Delft. GenScript leases around 650 m2 in Van Iterson House as of April 1, Lesaffre leases around 690 m2 in Beijerinck Center as of April 1. Both office and laboratory buildings are owned by the ASR Dutch Science Park Fund, which took over the buildings from dsm-firmenich last year.

Martin Kraaij, fund director ASR Dutch Science Park Fund: "By investing in office and laboratory buildings on the Biotech Campus Delft, we can offer companies such as GenScript and Lesaffre a place where they can work on innovations and products that contribute to the world of tomorrow. In this way, the ASR Dutch Science Park Fund has a positive impact on the ecosystems of science parks and supports the Dutch knowledge economy."

Cindy Gerhardt, Managing Director of Planet B.io, shares: "We are happy to welcome GenScript and Lesaffre to our community. As established global players in biotechnology and fermentation, they bring valuable expertise in synthetic biology, bioprocessing, and industrial applications. We are sure they will add tremendous value to our ecosystem by sharing their knowledge, collaborating with fellow innovators, and strengthening the biotech landscape here at our campus and in the Netherlands.”

GenScript
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,500 employees and has served more than 200,000 customers across over 100 countries and regions. By moving into the ground floor of Van Iterson House, GenScript is taking a significant step in establishing an mRNA lab in Europe.

Lesaffre
Lesaffre is a global leader in the field of fermentation and biotechnology. It was founded in 1853, and its headquarters is located in France. On October 1, 2024, the company opened its first Dutch office at the Biotech Campus Delft, following the acquisition of the yeast extract activities of dsm-firmenich. This strategic step enabled the company to further grow the processing technologies for yeast derivatives. As of April 1, Lesaffre has moved to the 2nd floor of the Beijerinck Center.

Biotech Campus Delft
The ASR Dutch Science Park Fund and dsm-firmenich have a long-term partnership to further develop the Biotech Campus Delft into a global leader in biosciences. Planet B.io builds on the unique innovation ecosystem by supporting companies in their ambition to make the world more sustainable based on biotechnological developments. This includes talent development, entrepreneurship, equipped labs for education and start-ups, growth labs and offices, and access to a broad network of experts in upscaling, financing, business and government.